These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group. Kissel JT; McDermott MP; Natarajan R; Mendell JR; Pandya S; King WM; Griggs RC; Tawil R Neurology; 1998 May; 50(5):1402-6. PubMed ID: 9595995 [TBL] [Abstract][Full Text] [Related]
5. New treatment alternatives for Duchenne and Becker muscular dystrophy. Restrepo S Neurology; 2004 Mar; 62(6):E10. PubMed ID: 15037729 [No Abstract] [Full Text] [Related]
6. Strength training and albuterol in facioscapulohumeral muscular dystrophy. van der Kooi EL; Vogels OJ; van Asseldonk RJ; Lindeman E; Hendriks JC; Wohlgemuth M; van der Maarel SM; Padberg GW Neurology; 2004 Aug; 63(4):702-8. PubMed ID: 15326246 [TBL] [Abstract][Full Text] [Related]
7. Drug treatment for facioscapulohumeral muscular dystrophy. Rose MR; Tawil R Cochrane Database Syst Rev; 2004; 2004(2):CD002276. PubMed ID: 15106171 [TBL] [Abstract][Full Text] [Related]
8. Evidence of muscle loss delay and improvement of hyperinsulinemia and insulin resistance in Duchenne muscular dystrophy supplemented with omega-3 fatty acids: A randomized study. Rodríguez-Cruz M; Atilano-Miguel S; Barbosa-Cortés L; Bernabé-García M; Almeida-Becerril T; Cárdenas-Conejo A; Del Rocío Cruz-Guzmán O; Maldonado-Hernández J Clin Nutr; 2019 Oct; 38(5):2087-2097. PubMed ID: 30420291 [TBL] [Abstract][Full Text] [Related]
9. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial. Campbell C; McMillan HJ; Mah JK; Tarnopolsky M; Selby K; McClure T; Wilson DM; Sherman ML; Escolar D; Attie KM Muscle Nerve; 2017 Apr; 55(4):458-464. PubMed ID: 27462804 [TBL] [Abstract][Full Text] [Related]
10. Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial. Mok E; Letellier G; Cuisset JM; Denjean A; Gottrand F; Alberti C; Hankard R PLoS One; 2009; 4(5):e5448. PubMed ID: 19421321 [TBL] [Abstract][Full Text] [Related]
11. Pilot trial of albuterol in spinal muscular atrophy. Kinali M; Mercuri E; Main M; De Biasia F; Karatza A; Higgins R; Banks LM; Manzur AY; Muntoni F Neurology; 2002 Aug; 59(4):609-10. PubMed ID: 12196659 [TBL] [Abstract][Full Text] [Related]
12. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. van der Kooi EL; Kalkman JS; Lindeman E; Hendriks JC; van Engelen BG; Bleijenberg G; Padberg GW J Neurol; 2007 Jul; 254(7):931-40. PubMed ID: 17361345 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial. Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977 [TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial. Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085 [TBL] [Abstract][Full Text] [Related]
18. Albuterol and exercise effects on ankle extensor strength during 40 days of unloading. Caruso JF; Hamill JL; Yamauchi M; Cook TD; Mercado DR; Wickel EE Aviat Space Environ Med; 2008 Jun; 79(6):577-84. PubMed ID: 18581941 [TBL] [Abstract][Full Text] [Related]